Consuming more nuts appears to be associated with improvements in blood cholesterol levels, according to a pooled analysis of data from 25 trials….
Read More »Modest Improvements in Fitness Reduces Mortality Risk in Diabetic Hypertensive Patients
In patients with hypertension and Type 2 diabetes, relatively modest improvements in fitness status — significantly with walking just 30 minutes a day — reduces mortality risk, according to a new study….
Read More »Prostate Meds Probed by the FDA for Risks of Diabetes and Heart Disease
The FDA announced that it’s reviewing the safety of a class of prostate cancer drugs, following up on data that suggest an increased risk of diabetes and certain heart problems….
Read More »Once Weekly Byetta (Bydureon © ) Delayed 6 Months by the FDA
Amylin Pharmaceuticals Inc said its resubmission for approval of a diabetes drug was classified by U.S. health regulators as a class 2 response, which typically suggests a review period of six months.…
Read More »GLP-1 Once-Weekly Analogue Taspoglutide Found Safe and Effective
Taspoglutide demonstrates superiority in HbA1c change versus placebo as add-on to metformin and pioglitazone….
Read More »Interruptions Associated with Medication Errors by Nurses
Nurses who are interrupted while administering medication appear to have an increased risk of making medication errors, according to a report.
Read More »Physical Activity Q & A with Dr. Sheri Colberg, Part 4
By Sheri Colberg, PhD Q: Dr. Sheri, I’ve been doing a lot of research on Type 2 diabetes and exercise. I have had Type 2 for five years. I am preparing for my first marathon. (I have raced halfs, 10K’s, 5K’s, etc….) My question relates to fasting insulin levels. I was …
Read More »Medicare Part D: A Boon for Industry and Insurers Alike
Issak Smith University of Florida PharmD Candidate In 2003, Congress passed the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) with the hope of reducing prescription drug costs for the nation’s seniors. It was implemented on January 1st, 2006. Now several years removed, and with healthcare reform again a hot …
Read More »MicroCHIPS, Inc., Honored with 2010 Edison Best New Product Award
MicroCHIPS, Inc., Honored with 2010 Edison Best New Product Award™ The Illume™ product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy. The technology will be used …
Read More »Tight Blood Sugar Control May Not Harm Diabetes Patients
Reanalysis of an ACCORD study refutes link between intensive therapy, higher death risk….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.